Docetaxel
Ingredients
Docetaxel
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| DocetaxelIngredients |
Extract from the above information More |
114977-28-5 | 49 |
Indication
1. It is suitable for the treatment of locally advanced or metastatic breast cancer. 2. It is suitable for the treatment of locally advanced or metastatic non-small cell lung cancer, even after the failure of cisplatin-based chemotherapy.
Usage and Dosage
Intravenous drip administration, single dose is 75-100 mg/m2, 75 mg/m2 is used in China, and 60-75 mg/m2 is used for combined use. Intravenous drip is 1 hour, repeated once every 3 weeks. In recent years, many scholars at home and abroad have adopted weekly therapy, generally with a single dose of 35-40 mg/m2, once a week, for 6 weeks, and stop for 2 weeks. It is recommended to start taking 8 mg of dexamethasone orally every day before using docetaxel, once every 12 hours, for 3 consecutive days. This product should be dissolved in the solvent provided, and then diluted with sodium chloride injection or 5% glucose to a final concentration of 0.3-0.9 mg/ml.
Adverse Reactions
Alopecia, weakness, mucositis, arthralgia and myalgia, hypotension, and injection site reactions.
Storage
Store at 2-8℃ in a sealed container and away from light.
Manufacturer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
-
Founded in:
2003-01-14 -
Address:
No. 699, Kejian Road, Jiangning Science Park, Nanjing -
Tax NO.:
91320100745398965U -
Registered Funds:
768 million yuan -
Website:
-
Email: